• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Ablation Technologies Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020 Product Image

Ablation Technologies Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020

  • Published: August 2014
  • Region: Global
  • 104 Pages
  • Transparency Market Research

FEATURED COMPANIES

  • AngioDynamics, Inc.
  • AtriCure, Inc.
  • Biosense Webster Inc.
  • BSD Medical Corporation
  • Covidien plc
  • Medtronic, Inc.
  • MORE

'Ablation Technologies Market (Applications: Cardiovascular, Gynecology, Pain Management, Oncology, Urology, Ophthalmology; Technologies: Radiofrequency, Light/Laser, Electrical, Ultrasound, Microwave, Cryotherapy) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020'

An ablation procedure is a minimally invasive process to remove unwanted tissue from the body by using various energy devices such as radiofrequency, microwave, ultrasound, electrical current, laser and others. The ablation devices are consisting of catheters, generators and other monitoring equipments. Ablation technologies are majorly employed for surgical procedures in cardiological disorders such as atrial fibrillation, arrhythmia, refractory hypertension and others; along with this, removal of cancerous and non cancerous tumors is also important application of ablation devices. As ablation surgeries are minimally invasive nature, it reduces post surgical complications and gives more accurate and successful results, therefore market for ablation technologies have high growth potential in coming future.

Global ablation technologies market is analyzed on the basis of technologies READ MORE >

Chapter 1 Introduction
1.1 Report Description
1.2 Research Methodology
1.2.1 Sources
1.2.1.1 Secondary Research
1.2.1.2 Primary Research
1.2.1.3 Assumptions
1.3 Market Segmentation
1.4 List of Abbreviations

Chapter 2 Executive Summary
2.1 Comparative Analysis: Global Ablation Technologies Market, by Geography, 2013 & 2020 (Value %)

Chapter 3 Market Overview
3.1 Introduction
3.2 Event Impact Analysis
3.3 Value Chain Analysis: Global Ablation Technologies Market
3.4 Regulatory and Reimbursement Overview
3.5 Porter’s Five Force Analysis: Global Ablation Technologies Market
3.5.1 Bargaining Power of Buyers
3.5.2 Bargaining Power of Supplier
3.5.3 Threat from Substitutes
3.5.4 Threat form New Entrant
3.5.5 Competitive Rivalry
3.6 Market Attractiveness Analysis: Global Ablation Technologies Market, by Geography
3.7 Competitive Landscape
3.7.1 Market Share by Key Players, 2013 (Value %)

Chapter 4 Global Ablation Technologies Market, by Application
4.1 Overview
4.1.1 Global Ablation Technologies Market Revenue, by Application, 2012-2020 (USD Million)
4.2 Comparative Analysis: Global Ablation Technologies Market, by Application, 2013 & 2020 (Value %)
4.3 Cardiovascular
4.3.1 Global Ablation Technologies Market Revenues, by Cardiovascular Application, 2012-2020 (USD Million)
4.4 Gynecology
4.4.1 Global Ablation Technologies Market Revenues, by Gynecology Application, 2012-2020 (USD Million)
4.5 Pain Management
4.5.1 Global Ablation Technologies Market Revenues, by Pain Management Application, 2012-2020 (USD Million)
4.6 Oncology
4.6.1 Global Ablation Technologies Market Revenues, by Oncology Application, 2012 - 2020 (USD Million)
4.7 Urology
4.7.1 Global Ablation Technologies Market Revenues, by Urology, 2012 - 2020 (USD Million)
4.8 Ophthalmology
4.8.1 Global Ablation Technologies Market Revenues, by Ophthalmology, 2012 - 2020 (USD Million)
4.9 Others
4.9.1 Global Others Market Revenue, 2012 - 2020 (USD Million)

Chapter 5 Global Ablation Technologies Market, by Technology
5.1 Overview
5.1.1 Global Ablation Technologies Market Revenue, by Technology, 2012 - 2020 (USD Million)
5.2 Comparative Analysis: Global Ablation Technologies Market, by Technology, 2013 & 2020 (Value %)
5.3 Radiofrequency
5.3.1 Global Radiofrequency Ablation Technologies Market Revenue, 2012 - 2020 (USD Million)
5.4 Light/Laser
5.4.1 Global Light/Laser Ablation Technologies Market Revenue, 2012 - 2020 (USD Million)
5.5 Electrical
5.5.1 Global Electrical Ablation Technologies Market Revenue, 2012-2020 (USD Million)
5.6 Ultrasound
5.6.1 Global Ultrasound Ablation Technologies Market Revenue, 2012-2020 (USD Million)
5.7 Microwave
5.7.1 Global Microwave Ablation Technologies Market Revenue, 2012-2020 (USD Million)
5.8 Cryotherapy
5.8.1 Global Cryotherapy Ablation Technologies Market Revenue, 2012-2020 (USD Million)
5.9 Others
5.9.1 Global Others Market Revenue, 2012-2020 (USD Million)

Chapter 6 Global Ablation Technologies Market, by Geography
6.1 Overview
6.1.1 Global Ablation Technology Market Revenue, by Geography, 2012-2020 (USD Million)
6.2 North America
6.2.1 North America Ablation Technologies Market Revenue, 2012-2020 (USD Million)
6.3 Europe
6.3.1 Europe Ablation Technologies Market Revenue, 2012-2020 (USD Million)
6.4 Asia Pacific
6.4.1 Asia-Pacific Ablation Technologies Market Revenue, 2012-2020 (USD Million)
6.5 Rest of the World (RoW)
6.5.1 Rest of the World Ablation Technologies Market Revenue, 2012-2020 (USD Million)

Chapter 7 Recommendations
7.1 Long term contracts with medical device manufacturers to strengthen the market presence
7.2 Enhancing distribution networks

Chapter 8 Company Profiles
8.1 AngioDynamics, Inc.
8.1.1 Company Overview
8.1.2 Financial Overview
8.1.3 Product Portfolio
8.1.4 Business Strategies
8.1.5 Recent Developments
8.2 AtriCure, Inc.
8.2.1 Company Overview
8.2.2 Financial Overview
8.2.3 Product Portfolio
8.2.4 Business Strategies
8.2.5 Recent Developments
8.3 Biosense Webster Inc.
8.3.1 Company Overview
8.3.2 Financial Overview
8.3.3 Product Portfolio
8.3.4 Business Strategies
8.3.5 Recent Developments
8.4 Boston Scientific Corporation
8.4.1 Company Overview
8.4.2 Financial Overview
8.4.3 Product Portfolio
8.4.4 Business Strategies
8.4.5 Recent Developments
8.5 BSD Medical Corporation
8.5.1 Company Overview
8.5.2 Financial Overview
8.5.3 Product Portfolio
8.5.4 Business Strategies
8.5.5 Recent Developments
8.6 Covidien plc
8.6.1 Company Overview
8.6.2 Financial Overview
8.6.3 Product Portfolio
8.6.4 Business Strategies
8.6.5 Recent Developments
8.7 Medtronic, Inc.
8.7.1 Company Overview
8.7.2 Financial Overview
8.7.3 Product Portfolio
8.7.4 Business Strategies
8.7.5 Recent Developments
8.8 St. Jude Medical, Inc.
8.8.1 Company Overview
8.8.2 Financial Overview
8.8.3 Product portfolio
8.8.4 Business Strategies
8.8.5 Recent Developments
8.9 Urologix, Inc.
8.9.1 Company Overview
8.9.2 Financial Overview
8.9.3 Product Portfolio
8.9.4 Business Strategies
8.9.5 Recent Developments

List of Figures:

FIG. 1 Ablation Technologies Market Segmentation
FIG. 2 Global Ablation Technologies Market, by Application, 2013 (USD Million)
FIG. 3 Global Ablation Technologies Market, by Technologies, 2013 (USD Million)
FIG. 4 Comparative Analysis: Global Ablation Technologies Market, by Geography, 2013 & 2020 (Value %)
FIG. 5 Global Ablation Technologies Market Value Chain Analysis
FIG. 6 Porter’s Five Forces Analysis: Global Ablation Technologies Market
FIG. 7 Market Attractiveness Analysis: Global Ablation Technologies Market, by Geography
FIG. 8 Ablation Technologies: Market Share by Key Players, 2013 (Value %)
FIG. 9 Comparative Analysis: Global Ablation Technologies Market, by Application, 2013 & 2020 (Value %)
FIG. 10 Global Ablation Technologies Market Revenues, by Cardiovascular Application, 2012-2020 (USD Million)
FIG. 11 Global Ablation Technologies Market Revenues, by Gynecology, 2012-2020 (USD Million)
FIG. 12 Global Ablation Technologies Market Revenues, by Pain Management, 2012-2020 (USD Million)
FIG. 13 Global Ablation Technologies Market Revenues, by Oncology, 2012-2020 (USD Million)
FIG. 14 Global Ablation Technologies Market Revenues, by Urology, 2012-2020 (USD Million)
FIG. 15 Global Ablation Technologies Market Revenues, by Ophthalmology, 2012-2020 (USD Million)
FIG. 16 Global Others Market Revenue, 2012 - 2020 (USD Million)
FIG. 17 Comparative Analysis: Global Ablation Technologies Market, by Technologies, 2013 & 2020 (Value %)
FIG. 18 Global Radiofrequency Ablation Technologies Market Revenue, 2012-2020 (USD Million)
FIG. 19 Global Light/Laser Ablation Technologies Market Revenue, 2012-2020 (USD Million)
FIG. 20 Global Electrical Ablation Technologies Market Revenue, 2012-2020 (USD Million)
FIG. 21 Global Ultrasound Ablation Technologies Market Revenue, 2012-2020 (USD Million)
FIG. 22 Global Microwave Ablation Technologies Market Revenue, 2012 - 2020 (USD Million)
FIG. 23 Global Cryotherapy Ablation Technologies Market Revenue, 2012-2020 (USD Million)
FIG. 24 Global Others Market Revenue, 2012 - 2020 (USD Million)
FIG. 25 North America Ablation Technologies Market Revenue, 2012-2020 (USD Million)
FIG. 26 Europe Ablation Technologies Market Revenue, 2012-2020 (USD Million)
FIG. 27 Asia-Pacific Ablation Technologies Market Revenue, 2012 - 2020 (USD Million)
FIG. 28 Rest of the World Ablation Technologies Market Revenue, 2012 - 2020 (USD Million)
FIG. 29 3M Company: Net Sales, 2010 - 2012 (USD Million)
FIG. 30 Ambu A/S: Annual Revenue, 2010 - 2012 (USD Million)
FIG. 31 Biosense Webster Inc.: Annual Revenue, 2010 - 2012 (USD Million)
FIG. 32 Boston Scientific Corporation: Net Sales: 2010- 2012(USD million)
FIG. 33 BSD Medical Corporation: Annual Revenue, 2010 - 2012 (USD Million)
FIG. 34 Covidien plc: Annual Revenue, 2010 - 2012 (USD Million)
FIG. 35 Medtronic, Inc.: Annual Revenue, 2010 - 2012 (USD Million)
FIG. 36 St. Jude Medical, Inc.: Annual Revenue, 2010 - 2012 (USD Million)
FIG. 37 Urologix, Inc.: Annual Revenue, 2010 - 2012 (USD Million)

List of Tables:

TABLE 1 List of Abbreviations
TABLE 2 Market Snapshot: Global Ablation Technologies Market
TABLE 1 Event Impact Analysis, 2012 - 2020
TABLE 2 Global Ablation Technologies Market Revenue, by Application, 2012 - 2020 (USD Million)
TABLE 3 Global Ablation Technologies Market Revenue, by Technologies, 2012 - 2020 (USD Million)
TABLE 4 Global Ablation Technologies Market Revenue, by Geography, 2012-2020 (USD Million)

Ablation technologies based surgeries are minimally invasive and are emerging as an alternative to primitive invasive surgical procedures. Ablation involves either complete destruction or removal of abnormal tissue with the aim to cure the disease. Ablation technologies market can be segmented into two prominent categories namely thermal ablation and non-thermal ablation. The thermal ablation technology encompasses radiofrequency, microwave, ultrasound, hydrothermal, electrical and light/laser technologies whereas, cryoablation technology falls under non-thermal ablation category. The principal advantage of these procedures over surgery is short recovery time, minimum invasion, low risk of infection, lesser blood loss, and shorter hospital stays. Ablation technologies have applications in various clinical areas such as cancer, cardiac, ophthalmology, urology, gynecology and orthopedics. The report also provides the compound annual growth rate (CAGR %) for each of the segments for the forecast period 2014-2020, while market size estimations have been made considering 2012 and 2013 as base years.

The global market for ablation technologies market has been studied on the basis of application type and technologies type. The application segment has been sub-segmented into these prominent categories namely cardiovascular, gynecology, pain management, oncology, urology, ophthalmology and others. Whereas, the ablation technologies market has been fragmented into radiofrequency, light/laser, electrical, ultrasound, microwave, cryotherapy and others. RF ablation is the most established device type, but ultrasound ablation and cryoablation are growing rapidly owing to advantages associated such as minimal damage to associated tissues among others. Cryoablation devices are the only kind of ablation device that can be used to treat prostate cancer. Urologists and interventional radiologists both use cryoablation to treat kidney cancer using differing techniques. As per an analysis by Center for Disease Prevention and Control (CDC) approximately 5.1 million people face heart failure every year of which one in nine deaths in 2009 were primarily due to cardiac arrhythmia. As per WHO projection, approximately 32 million people are living with some form cancer causing 8 million deaths across the world which clearly depicts scope of opportunities for players operating in the ablation technologies market.

Other prominent drivers to the global ablation technologies market include increasing adoption of ablation techniques and devices in cosmetics such as varicose vein treatment, psoriasis among others are key areas of opportunities in developing economic countries. Restraints to the ablation technologies market include disparities in the reimbursement scenario across globe along with regulations to curb pricing pressure which include Affordable Care Act and deployment of Accountable Care Organization especially in developed economic regions, thus affecting the overall growth and uptake of the ablation devices. Furthermore, high procedural cost is main area of concern for companies operating in this market.

Geographically, North America which includes the United States and Canada continues to be a leading market in ablation technologies. The United States market accounts for major contribution owing to larger population base, larger penetration of healthcare services and wider acceptance of these novel technologies. Although Canada’s contribution in North America revenue is significantly low as compared to the United States yet there has been a shift in trend towards adoption of novel ablation technologies such as radiation and microwave ablation therapies in past couple of years. Pertaining to the adoption rate, the market for ablation products is likely to grow exponentially in forthcoming years. An estimated 191,300 new cases of cancer and 76,600 deaths from cancer will occur in Canada in 2014 accounting for 30% of overall deaths. About 52% of all the new cases of cancer in Canada will include prostate, breast, lung and colorectal cancers. Companies like Medtronic in 2008, looking at the untapped opportunities in Canadian market acquired Montreal based CryoCath Technologies Inc. to form Medtronic’s AF Solutions division which as of now offers an extensive line of diagnostic, cryoablation and radiofrequency ablation tools to diagnose and treat a broad spectrum of cardiac arrhythmias.

Asia-Pacific region during the forecast is the fastest growing region owing to larger population base of patients suffering from cardiovascular, cancer and arthritis and other orthopedic disorders. Overall drivers to Asia-Pacific market for ablation technologies include increasing healthcare awareness, rise in healthcare expenditure and increase in chronic diseases due to change in lifestyle and food habits. Rest of the World market is still at nascent stage and is expected to grow considering continuous rise in prevalence rate of hypertension, cardiovascular and urological diseases.

Some of the key companies operating in this market include St. Jude Medical, Inc., Bioscience Webster Inc., Medtronic, Inc., Boston Scientific Corp, Covidien PLC and Angiodynamics, Inc. among others.

- AngioDynamics, Inc.
- AtriCure, Inc.
- BSD Medical Corporation
- Biosense Webster Inc.
- Boston Scientific Corporation
- Covidien plc
- Medtronic, Inc.
- St. Jude Medical, Inc.
- Urologix, Inc.

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos